Advertisement.

CNBX Projected Dividend Yield

CNBX Pharmaceuticals Inc ( OTCBB : CNBX )

CNBX Pharmaceuticals is engaged in the discovery, development and commercialization of cannabinoid-based products and various technologies for the treatment of cancer. Co.'s primary product candidate is RCC-33, an oral capsule for the treatment of colorectal cancer. In addition, Cannabics SR is a lipid-based capsule containing a standardized formulation of cannabinoids that Co. is developing as a product candidate for the treatment of cancer anorexia-cachexia syndrome. Another product candidate Co. is developing is Cannabics CDx, a drug sensitivity test designed to provide decision support to healthcare providers interested in personalizing cannabinoid-based cancer therapies.

20 YEAR PERFORMANCE RESULTS

CNBX Dividend History Detail
CNBX Dividend News
CNBX Competitors News

# of Shares: 0

Closing Price: 0.01

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000